MRSN - Mersana Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MRSN is currently covered by 8 analysts with an average price target of $6.19. This is a potential upside of $5.84 (1668.57%) from yesterday's end of day stock price of $0.35.

Mersana Therapeutics's activity chart (see below) currently has 36 price targets and 41 ratings on display. The stock rating distribution of MRSN is 58.82% BUY and 41.18% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 32.78% with an average time for these price targets to be met of 248.92 days.

Highest price target for MRSN is $5, Lowest price target is $5, average price target is $6.6.

Most recent stock forecast was given by ASHIK KURIAN from CITI on 15-Nov-2024. First documented stock forecast 24-Jul-2017.

Currently out of the existing stock ratings of MRSN, 10 are a BUY (58.82%), 7 are a HOLD (41.18%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$5

$3.61 (259.71%)

$1

5 months 3 days ago
(15-Nov-2024)

0/4 (0%)

$2.65 (112.77%)

Buy

$7

$5.61 (403.60%)

$2

1 years 1 months 20 days ago
(29-Feb-2024)

3/6 (50%)

$1.56 (28.68%)

191

Buy

$9

$7.61 (547.48%)

1 years 1 months 20 days ago
(29-Feb-2024)

0/2 (0%)

$3.56 (65.44%)

Buy

$7

$5.61 (403.60%)

$14

1 years 1 months 20 days ago
(29-Feb-2024)

1/3 (33.33%)

$1.56 (28.68%)

1072

Hold

$5

1 years 8 months 23 days ago
(27-Jul-2023)

2/3 (66.67%)

$1.46 (19.97%)

48

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MRSN (Mersana Therapeutics) average time for price targets to be met?

On average it took 248.92 days on average for the stock forecasts to be realized with a an average price target met ratio 32.78

Which analyst has the current highest performing score on MRSN (Mersana Therapeutics) with a proven track record?

MICHAEL ULZ

Which analyst has the most public recommendations on MRSN (Mersana Therapeutics)?

Michael Ulz works at MORGAN STANLEY and has 14 price targets and 11 ratings on MRSN

Which analyst is the currently most bullish on MRSN (Mersana Therapeutics)?

Michael Ulz with highest potential upside - $25.74

Which analyst is the currently most reserved on MRSN (Mersana Therapeutics)?

Jessica Fye with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?